アブサイ
Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.19 | $215,000 | -$26M |
| 2025 Q4 | -0.20 | $650,000 | -$29M |
| 2025 Q3 | -0.20 | $378,000 | -$26M |
| 2025 Q2 | -0.24 | $593,000 | -$17M |
| 2025 Q1 | -0.21 | $1M | -$22M |
| 2024 Q4 | -0.25 | $665,000 | -$17M |
| 2024 Q3 |
| -0.24 |
| $2M |
| -$21M |
| 2024 Q2 | -0.22 | $1M | -$17M |